Data gathered: May 11
AI Stock Analysis - Edwards Lifesciences (EW)
Analysis generated October 24, 2024. Powered by Chat GPT.
Edwards Lifesciences Corporation is a prominent American medical equipment company. Renowned for its innovative heart valve products, it primarily designs, manufactures, and markets technologies for structural heart disease, especially in relation to critical care and surgical monitoring. The company’s key product lines include transcatheter heart valves, surgical heart valves, and critical care products. With a focus on heart-related medical devices, Edwards Lifesciences serves a critical role in the healthcare sector and sees steady demand for its life-saving technologies.
Stock Alerts - Edwards Lifesciences (EW)
 |
Edwards Lifesciences | May 10 Insider Alert: Lippis Daniel J. is selling shares |
|
Edwards Lifesciences | May 10 Rob Bresnahan (member of U.S. congress) is buying shares |
|
Edwards Lifesciences | May 9 Jefferson Shreve (member of U.S. congress) is buying shares |
|
Edwards Lifesciences | May 7 Insider Alert: Zovighian Bernard J is selling shares |
Download our app to get future alerts delivered in real-time.
Alternative Data for Edwards Lifesciences
About Edwards Lifesciences
Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease. It manufactures heart valves and repair products used to replace or repair a patient's diseased or defective heart valve.
| Price | $73.68 |
| Target Price | Sign up |
| Volume | 3,800,000 |
| Market Cap | $43.2B |
| Year Range | $64.54 - $76.28 |
| Dividend Yield | 0% |
| PE Ratio | 30.45 |
| Analyst Rating | 45% buy |
| Industry | Medical Devices |
In the news
Edwards Lifesciences : Annual Stockholder Meeting TranscriptMay 9 - Finnhub |
|
Why Edwards Lifesciences (EW) Is Among the Best Medical Device Stocks to Buy NowMay 9 - Yahoo Entertainment |
|
 |
Edwards Lifesciences First Quarter 2025 Earnings: EPS Beats ExpectationsMay 7 - Yahoo |
 |
Reviewing Anteris Technologies Global (NASDAQ:AVR) and Edwards Lifesciences (NYSE:EW)May 6 - ETF Daily News |
|
Edwards Lifesciences to Present at the BofA Securities 2025 Health Care ConferenceMay 5 - Yahoo |
|
Edwards Lifesciences (NYSE:EW) Receives FDA Approval For Groundbreaking TAVR Therapy For Asymptomatic PatientsMay 2 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 1.41B | 300M | 1.11B | 358M | 434M | 0.640 |
| Q4 '24 | 1.39B | 292M | 1.09B | 386M | 484M | 0.590 |
| Q3 '24 | 1.35B | 263M | 1.09B | 3.07B | 437M | 0.670 |
| Q2 '24 | 1.39B | 298M | 1.09B | 366M | 417M | 0.700 |
| Q1 '24 | 1.6B | 384M | 1.21B | 352M | 476M | 0.660 |
Insider Transactions View All
| Lippis Daniel J. filed to sell 26,616 shares at $74.4. May 9 '25 |
| Ullem Scott B. filed to sell 41,098 shares at $74.4. May 9 '25 |
| Markowitz Wayne filed to sell 9,299 shares at $75.1. May 9 '25 |
| Zovighian Bernard J filed to sell 58,284 shares at $74.9. May 6 '25 |
| BOBO DONALD E JR filed to sell 47,206 shares at $69.8. April 14 '25 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Jefferson Shreve |
May 9, 25 | Buy | $15K - $50K |
| Rob Bresnahan |
May 8, 25 | Buy | $1K - $15K |
| Bruce Westerman |
Apr 17, 25 | Buy | $1K - $15K |
Read more about Edwards Lifesciences (EW) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Edwards Lifesciences?
The Market Cap of Edwards Lifesciences is $43.2B.
What is Edwards Lifesciences' PE Ratio?
As of today, Edwards Lifesciences' PE (Price to Earnings) ratio is 30.45.
What is the current stock price of Edwards Lifesciences?
Currently, the price of one share of Edwards Lifesciences stock is $73.68.
How can I analyze the EW stock price chart for investment decisions?
The EW stock price chart above provides a comprehensive visual representation of Edwards Lifesciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Edwards Lifesciences shares. Our platform offers an up-to-date EW stock price chart, along with technical data analysis and alternative data insights.
Does EW offer dividends to its shareholders?
As of our latest update, Edwards Lifesciences (EW) does not offer dividends to its shareholders. Investors interested in Edwards Lifesciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Edwards Lifesciences?
Some of the similar stocks of Edwards Lifesciences are Boston Scientific, Intuitive Surgical, Medtronic, Stryker, and Becton Dickinson and Co.
.